US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News EU regulator wants more advanced therapies Only a handful of products have reached the market in eight years.
News FDA asks for more data on Sarepta's muscular dystrophy drug Regulator asks for more data from ongoing trial.
Cancer Novartis' Afinitor gets new EU cancer use Novartis’ Afinitor has been approved in a new cancer indication in Europe – but faces potential competition from newer drugs.
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
